0001103021-21-000002.txt : 20210120
0001103021-21-000002.hdr.sgml : 20210120
20210120163026
ACCESSION NUMBER: 0001103021-21-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210115
FILED AS OF DATE: 20210120
DATE AS OF CHANGE: 20210120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coelho Mary Theresa
CENTRAL INDEX KEY: 0001720772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 21539112
MAIL ADDRESS:
STREET 1: 52 SUNRISE PARK ROAD
CITY: NEW HAMPTON
STATE: NY
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_161117821292460.xml
FORM 4
X0306
4
2021-01-15
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001720772
Coelho Mary Theresa
C/O BIODELIVERY SCIENCES INTL, INC.
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
0
1
0
0
See Remarks
Common Stock
2021-01-15
4
M
0
18333
0
A
30351
D
Common Stock
2021-01-19
4
S
0
6462
4.32
D
23889
D
Restricted Stock Units
0.0
2021-01-15
4
M
0
18333
0
D
2020-01-15
2022-01-17
Common Stock
18333.0
18334
D
The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
On January 19, 2021, the Reporting Person sold an aggregate of 6,462 shares of the Issuer's Common Stock at a weighted average price of $4.32 per share. The highest sale price for the Common Stock was $4.34 per share and the lowest sale price was $4.32 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
The shares of common stock were acquired by the Reporting Person as a result of the vesting of 18,333 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant vest on January 15, 2022.
Chief Financial Officer and Treasurer
/s/ Mary Theresa Coelho
2021-01-20